Redx Pharma nonexecutive director resigns
Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet
Insight Weekly: Stocks limp into 2023; GCC banks set for rebound; deep-sea mining faces pushback
Infographic: The Big Picture 2023 Sustainability Outlook
The Big Picture for 2023: Assessing Investment Trends and the Impact of Investor Activism
Redx Pharma PLC said David Lawrence resigned as a nonexecutive director of the company.
Lawrence said he will focus on a recently commenced executive role. He also said the company will likely exit administration.
